Floatz logo

MENOTROPHIN

Gonadal Disorders

Royan InstitutemixturePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Gonadal Disorders cohort.

Asset / SponsorPhaseRating
Metformin
University of Colorado, Denver
Phase 4BB
Niraparib
Xiaoxiang Chen
Phase 2CCC
CLOMIPHENE CITRATE
Royan Institute
Phase 1/2CCC
Hcg
Royan Institute
Phase 1/2CCC

Same molecule, other indications

MENOTROPHIN is also rated in:

polycystic ovary syndromeDormant
BB
Indicative ·
69 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
68 / 100
View asset →
infertility disorderDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →